Cholesterol-linked drug boosts gene-targeting potency in early findings
Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a variety of previously hard-to-treat diseases, including neurological diseases.
Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a variety of previously hard-to-treat diseases, including neurological diseases. This story matters for Science & Discovery readers tracking insect. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. InsectNews.com curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily insect signal